317 related articles for article (PubMed ID: 26373755)
1. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
3. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
Davis K; Kielar A; Jafari K
Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
[TBL] [Abstract][Full Text] [Related]
5. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.
Balageas P; Cornelis F; Le Bras Y; Hubrecht R; Bernhard JC; Ferrière JM; Ravaud A; Grenier N
Eur Radiol; 2013 Jul; 23(7):1925-32. PubMed ID: 23443351
[TBL] [Abstract][Full Text] [Related]
6. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
[TBL] [Abstract][Full Text] [Related]
7. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
8. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
[TBL] [Abstract][Full Text] [Related]
9. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
10. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
Kim HJ; Park BK; Chung IS
Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of CT-guided percutaneous radiofrequency ablation of adrenal metastases.
Zhou K; Pan J; Yang N; Shi HF; Cao J; Li YM; Zhang HZ; Wang KF; Chen SH
Br J Radiol; 2018 May; 91(1085):20170607. PubMed ID: 29350539
[TBL] [Abstract][Full Text] [Related]
12. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
13. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
14. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
15. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
16. Renal function outcomes for multifocal renal neoplasms managed by radiofrequency ablation.
Gupta P; Allen BC; Chen MY; Childs DD; Kota G; Zagoria RJ
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1329-35. PubMed ID: 23361116
[TBL] [Abstract][Full Text] [Related]
17. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
Zhou W; Herwald SE; Uppot RN; Arellano RS
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]